Tryptophan hydroxylase-2 (TPH2) is a newly identified second form of TPH responsible for serotonin synthesis in the brain and has been increasingly implicated as a contributor to the etiology of various psychiatric disorders. In this study, we have identified the constellation of polymorphisms in rhesus monkey TPH2 and investigated genotype/phenotype association as well as gene expression effects of specific polymorphisms. Genomic DNA was obtained from 247 rhesus monkeys, among which 24 had been previously examined for plasma cortisol level, dexamethasone suppression, and combined dexmethasone/ACTH challenge. Polymorphisms in all exons, splicing junctions and approximately 2 kb of the 5 0 -flanking region (5 0 -FR) of TPH2 were identified by sequencing. We identified 17 single nucleotide polymorphisms (SNPs) including two that are predictive of amino-acid change (25Pro > His and 75Gly > Ser, respectively), two mononucleotide repeats, one dinucleotide repeat, and one 159-bp insertion polymorphism. The 3 0 -UTR polymorphisms were significantly associated with hypothalamicpituitary-adrenal (HPA) axis activity, especially 2051A > C, which was strikingly correlated with plasma cortisol level in the morning only (F = 10.203, P = 0.001). Luciferase reporter gene assays showed that the 3 0 -UTR polymorphisms and haplotypes had a profound effect on in vitro gene expression. Accordingly, these investigations revealed that polymorphisms in 3 0 -UTR of rhesus monkey TPH2 modulate HPA axis function, presumably by affecting levels of TPH2 expression. Molecular Psychiatry (2006) 11, 914-928.
Introduction
Dysfunction of the serotonin (5-HT) system is implicated in the etiology of many psychiatric disorders including depression, autism, schizophrenia, drug abuse and addiction, suicide and attention-deficit/ hyperactivity disorder (ADHD), and a variety of efficacious pharmaceuticals which modulate the synthesis, signal transduction, transport and catabolism of 5-HT have been used to treat various psychiatric diseases. Tryptophan hydroxylase (TPH) is the first and rate-limiting enzyme in the biosynthesis of 5-HT, converting the amino-acid tryptophan to 5-hydroxytryptophan which is then further decarboxylated into 5-HT. 1, 2 There are two isoforms of TPH that share a large degree of structural similarity, referred to as TPH1 and TPH2. The TPH2 isoform is the product of a recently discovered second gene, TPH2, which is exclusively expressed in the brain in a circadian rhythm and is responsible for the neuronal 5-HT synthesis, whereas the TPH1 isoform is primarily expressed in peripheral tissues by TPH1. [2] [3] [4] [5] [6] Thus, upon its identification, TPH2 has attracted much attention with respect to its role in the pathophysiology of various psychiatric disorders. TPH2 genetic variance has been reported to be associated with major depression, [7] [8] [9] affective disorders, 10 suicidality, 9,11 autism, 12 early onset obsessive-compulsive disorder, 13 and ADHD. 14, 15 To date, two functional SNPs in human TPH2 have been reported. First, an extremely rare coding SNP, R441H, results in an approximate 80% loss of function in in vitro assays, and was reportedly associated with unipolar major depression, 8 but intriguingly this SNP, although verified in the original cohort by other investigators, was not found again. [16] [17] [18] [19] The second is a promoter region SNP, À844G > T, associated with increased amygdaloid activity in a facial emotion recognition paradigm measured by functional MRI, but not by gene expression assay. 20, 21 TPH2 genetic variance in rhesus monkeys may mimic in effect the variance with orthologous human alleles that, although likely consisting of different polymorphisms than occur in humans, nevertheless may share common function and phenotypic association to those implicated in neuropsychiatric and substance abuse disorders. In this regard, rhesus monkeys could potentially naturally model a component of the neurogenetic variance seen in human neuropsychiatric disorders. Accordingly, we determined the range of polymorphic variation in the rhesus monkey TPH2 coding and non-coding regions, as well as the effect of specific 3 0 -UTR polymorphisms on in vitro gene expression and their association with HPA axis function.
Materials and methods
Animal subjects and genomic DNA isolation Two hundred and forty seven rhesus monkeys (Macaca mulatta) housed at New England Primate Research Center were involved in this study, among which a cohort of 32 subjects had been behaviorally and physiologically characterized between 1994 and 2002. The 32 monkeys were all males and aged at 2-16 years when they were characterized. Animals used in this study were maintained in accordance with the guidelines of the Committee on Animals of the Harvard Medical School and the Guide for For each monkey, 2-8 ml of venous blood samples were collected in vacutainer tubes containing EDTA and genomic DNA was isolated from peripheral leukocytes by using a standard phenol/chloroform extraction method.
Cloning of rhesus monkey TPH2 coding region Fresh brain tissue was harvested from a rhesus monkey euthanized for other purposes. Dissected raphe nucleus tissue was immediately placed in RNAlater (Ambion Inc., Austin, TX, USA) and stored at 41C for < 1 week. Messenger RNA was extracted from homogenized tissue (Dounce Tissue Grinder, Kontes, VWR Scientific) using a Poly(A)Pure mRNA purification kit (Ambion Inc., Austin, TX, USA), and reverse transcribed using Superscript II RNase H À reverse transcriptase (Life Technologies, Rockville, MD, USA), according to the manufacturer's protocols. A series of primers listed in Table 1 were used for both amplification of raphe cDNA and DNA sequen- Upper case nucleotide(s) were modified for rhesus monkey TPH2 (TPH2-XbaI-F) or designed to introduce a mutation (hTPH2-m1f and hTPH2-m1r).
cing. Primer set TPH2-U5F2/U3R6 specific for human TPH2 (AY098914) yielded a product of expected size containing the full-length of TPH2 coding region, which was then sequenced and cloned into the pcDNA3.1/V5-His-TOPO vector (Invitrogen, Carlsbad, CA, USA). Sequence validity was confirmed independently with individual exon amplifications.
PCR amplifications and DNA sequencing
As the genomic sequence for rhesus monkey TPH2 was not available when this study began, we designed the primers on the basis of corresponding human genomic sequence (AC090109). To avoid PCR failure due to nucleotide difference between human and rhesus monkey, at least two sets of primers were designed for each amplification and some primers in 5 0 -FR were adjusted during the study. Eleven segments of the TPH2 gene, including all the exons, splicing junctions, and approximately 2 kb of the 5 0 -FR, were amplified from 52 DNA samples for polymorphism screening. The PCR primers were also used for sequencing reactions, and additional sequencing primers were applied if necessary. Primers for segmental amplification and sequencing are listed in detail in Table 2 . For clarity, we referred to the first nucleotide of the open reading frame (ORF) as nucleotide 1 (corresponding to nucleotide 30081 of AC090109), with the 5 0 -UTR beginning at À1 and proceeding in the negative direction. Nucleotide position in the introns (or intervening sequence, IVS) was counted from the initial 5 0 -nucleotide in the intron (positive numbers) or from the final 3 0 -nucleotide (negative numbers).
A touchdown PCR protocol was used for the amplifications in a PTC-225 Peltier Thermal Cycler (MJ Research, USA) in a total volume of 20 ml comprising 100 ng of genomic DNA, 10 pmoles of each primer, 200 mM of each dNTP 2 ml of 10 Â PC2 reaction buffer, and 1.5 U KlenTaq1 DNA polymerase (Ab Peptides Inc., St Louis, MO, USA). Amplification DNA sequencing was then performed using a CEQ 8000 Genetic Analysis System and CEQ DTSC Quick Start Kit (Beckman Coulter, Fullerton, CA, USA). Both strands were sequenced for most PCR products. As a 159-bp insertion polymorphism was identified in the 3 0 -UTR and the insert sequence is highly identical to a region within intron 9 of TPH2, we also sequenced part of the intron 9 from six samples.
For the segments likely to harbor repeat polymorphism(s), such is the case for the 5 0 -FR and exon 9, the purified PCR product was cloned into pGEM-T Easy Vector (Promega, Madison, WI, USA) using Blue/ White colony selection and the recombinant plasmid DNA was isolated using a Wizard Plus SV Minipreps DNA Purification System (Promega), followed by sequencing with a vector forward primer T7f (5 0 -taatacgactcactataggg-3 0 ) or PCR primers.
Assays for the detection of TPH2 polymorphisms
We suspected that polymorphisms located in the regulatory regions or resulting in amino-acid change would be of potential significance, and accordingly, we focused on polymorphisms in 5 0 -FR and 3 0 -UTR, together with the two missense coding SNPs (cSNPs). All 247 monkeys were genotyped for the 159-bp insertion polymorphism (2128S > L) in 3 0 -UTR by using amplicon size discrimination with primer set TPH2-U5F5/U5R5 (Table 2) . We developed PCRbased restriction fragment length polymorphism (PCR-RFLP) assays for all the SNPs in 5 0 -FR and 3 0 -UTR, as well as the two missense cSNPs. To allow for a genotype-phenotype association, only the common SNPs (À363T > G, 223G > A, 1503A > G and 2051A > C) were genotyped in the cohort of 32 monkeys. As the PCR-RFLP assay might be affected by either a nearby additional restriction site or the other amplicon, direct sequencing was also used for 2051A > C genotyping, while fluorescent hybridization probe melting analysis was developed for 223G > A genotyping.
For the fluorescent hybridization probe melting analysis, we designed primers and probes (Table 1) targeting the region around 223G > A with LightCycler Probe Design Software 2.0 (Roche Applied Science). Real-time PCR, followed by melting curve analysis for 223G > A genotyping, was performed on the LightCycler instrument 2.0 (Roche; software version 4.0). The master-mix reagent Fast Start DNA Master Hybridization Probes (Roche) was used and supplemented to 3.0 mM Mg 2 þ , 0.5 mM each of the TPH2-specific primers TPH2-E2F1 and TPH2-I2R3, and 0.2 mM each of the TPH2-specific fluorescence resonance energy transfer hybridization probes TPH2-E2P1 and TPH2-E2P2. PCR was carried out in 20 ml capillaries (2 ml of sample DNA and 18 ml of mastermix) at 951C for 3 min, followed by 40 cycles of 7 s at 951C, 5 s at 581C, and 9 s at 721C. Genotyping was performed by melting curve analysis: 951C for 0 s and 551C for 15 s, followed by a temperature increase from 55 to 851C (0.11C/s), with continuous fluorescence acquisition. Each assay run included a reagent control containing water instead of sample DNA.
Analysis of the HPA axis activity Plasma cortisol level, HPA negative feedback sensitivity and ACTH challenge response measurements were used to assess the HPA axis activity. The results of these studies of HPA activity were previously reported in Tiefenbacher et al. 22, 23 In December 1997, blood samples were collected from 22 of the 32 cohort monkeys to measure the plasma cortisol levels. Briefly, blood samples were collected twice for each monkey, once between 0830 h and 0900 h (AM sample) and again between 1530 and 1600 h (PM sample). At least 5 days elapsed between the morning and afternoon drawings for a given subject. Approximately half of the animals were sampled first in the morning, and the remaining animals were sampled first in the afternoon. Following the anesthetization with ketamine (10 mg/kg, i.m.), 10 ml of femoral blood was drawn from each monkey into two 5-ml EDTA-containing vacutainer tubes. The blood samples were chilled and centrifuged at 61C for 10 min at 10 000 r.p.m., and plasma was stored at À401C until analyzed in duplicate.
In the spring of 1999, HPA negative feedback sensitivity was examined in 19 monkeys (17 which were sampled in 1997 and 2 additional monkeys). Urine samples were collected continuously over a 3-day baseline period (BSL-1, BSL-2 and BSL-3). The collected urine was retrieved twice each day, at 0800 h and at 1600 h to estimate basal 24-h urinaryfree cortisol excretion. Upon completion of baseline sampling at 1600 h on BSL-3, a low dose of dexamethasone (12 mg/kg, i.m.) was administered. Dexamethasone-induced cortisol suppression was compared in two additional urine fractions collected at 0800 h (DEX-N) and at 1600 h (DEX-D) after the dexamethasone injection.
In the summer of 2000, 24 monkeys (all the 19 monkeys in 1999 study, another four monkeys in 1997 study, together with one additional monkey) were subjected to a combined dexamethasone/ACTH (DEX/ ACTH) challenge. After an overnight fast, a high dose of dexamethasone (0.5 mg/kg, i.m.) was administered to each subject at 0800 h to suppress endogenous HPA activity. At 1300 h, 5 h postinjection, subjects were anesthetized with 15 mg/kg of ketamine (i.m.) and a catheter was inserted into the right saphenous vein for both ACTH administration and serial blood sampling. Upon collection of an initial baseline blood sample, 10 ng/kg of synthetic ACTH (Cortrosyn, Organon Inc., West Orange, NJ, USA) was infused i.v. over a 60 s period and the cortisol response was monitored in two additional blood samples collected at 15 and 30 min post-ACTH. Additional ketamine (7.5 mg/kg, i.m.) was administered as necessary to maintain adequate sedation.
Plasma cortisol levels collected in 1997 and urinary free cortisol levels for dexamethasone suppression were determined using a commercially available radioimmunoassay (RIA) from ICN Biomedicals (Costa Mesa, CA, USA). The urinary cortisol was assayed at the same time with an intra-assay coefficient of variation (CV) of 7.3%, while the intra-and inter-assay CV for plasma cortisol were 10.4 and 11.9%, respectively. For the DEX/ACTH challenge, plasma levels of cortisol were measured using an RIA from Diagnostic Products Corporation (Los Angeles, CA, USA) with a reported cross-reactivity for dexamethasone of 0.04%. Intra-and inter-assay CV for plasma cortisol was 2.6 and 8.0%, respectively.
Construction of reporter plasmids
The 159-bp insertion polymorphism (2128S > L) and other two common SNPs in 3 0 -UTR were highly linked, constituting only three identified haplotypes (AAS, ACS and GAL). The whole TPH2 3 0 -UTR for each of these three haplotypes were amplified from genomic DNA by using primer set TPH2-XbaI-F and TPH2-BamHI-R (Table 1 ) and cloned into pRL-SV40 at 7 bp downstream from the Renilla luciferase coding region. The PCR products of ACS and GAL haplotypes were directly cloned into pRL-SV40 vector (Promega), while the pRL-SV40/AAS construct was generated by using restriction enzymes. An additional, synthetic pRL-SV40/AAL construct was made from pRL-SV40/ACS and pRL-SV40/GAL by using double digestion with BlpI and BamHI. The restriction enzyme BlpI does not recognize pRL-SV40 but cuts the 3 0 -UTR insert once between 1503A > G and 2051A > C. Following the sequential digestion with BlpI and BamHI, the long fragment of digested pRL-SV40/ACS (B3.5 kb, containing 1503A) and the short fragment of digested pRL-SV40/GAL (B900 bp, containing 2051A and 2128L) were purified and subjected to ligation with each other. After verification, the constructed pRL-SV40/AAL, together with the pRL-SV40/ACS, were subjected to HindIII digestion. The HindIII enzyme cuts the pRL-SV40 once at nucleotide 420 and additionally cuts the 3 0 -UTR insert once between 2051A > C and 2128S > L. Hence, the short (B1.8 kb, containing 1503A and 2051A) and long fragment (B2.4 kb, containing 2128S) of the HindIII-digested SV40/AAL and SV40/ACS, respectively, were ligated again to generate the pRL-SV40/ AAS construct. Selected constructs were sequenceverified and were in correct orientation.
To assess the potential significance of each polymorphism alone, as well as their synergic effect, all four haplotype constructs were included in subsequent luciferase reporter gene assays. In addition, we also sub-cloned all these 3 0 -UTR haplotypes from pRL-SV40 constructs into pRL-TK vector (Promega) by double digestion with XbaI and BamHI, as an additional control and to determine to some extent whether the effect of the haplotypes on gene expression was promoter-dependent. A schematic structure of these haplotype constructs is shown in Figure 9 . Moreover, as a common SNP (1952G > A, rs17110747) in human TPH2 3 0 -UTR is close to 2051A > C and its functional significance is still undetermined, we also examined its effect on in vitro gene expression. The whole TPH2 3 0 -UTR was amplified from human genomic DNA (Promega, Madison, WI, USA, catalog No. G1471 and G1521) by using primer set hTPH2-XbaI-F and TPH2-BamHI-R ( Table 1 ). The 3 0 -UTR PCR product containing 1952G allele was directly cloned into pRL-SV40 and then used as the template to generate the construct carrying 1952A allele. Two mutagenic primers, hTPH2-m1f and hTPH2-m1r (Table 1) , were used to generate the 1952A construct by using QuickChange Site-Directed Mutagenesis Kit (Stratagene, LA Jolla, CA, USA) according to the manufacturer's instruction. Both constructs were verified by sequencing.
Transient transfection and luciferase assays HEK-293 cells were cultured in Dulbecco's Modified Eagle's Medium containing 10% fetal bovine serum, 100 U/ml penicillin, 100 mg streptomycin and 0.1 mM nonessential amino acids, while SK-N-MC cells were grown in Ham's F12 Medium with 10% fetal bovine serum. Both cell lines were maintained at 371C in an atmosphere of 5% CO 2 . The day before transfection, cells were seeded in 24-well plates at approximately 2 Â 10 5 cells/well. The Promega ProFection Mammalian Transfection System was used to perform the transfection experiments according to the manufacturer's instruction. 1 mg of each haplotype construct was transfected along with a second firefly luciferase reporter vector (5 ng of pCDNA3.1/Luc or 100 ng of pTLNC121-3, a 21 Â CRE/fLuc reporter) as a control to determine transfection efficiency and plating variation. The transfected cells were maintained in culture and the growth medium was changed 4-12 h after transfection. The cells were harvested 24 h after transfection, and the activity of firefly luciferase and Renilla luciferase was measured using the Dual Luciferase Reporter Assay System (Promega) on a Berthold Lumat LB-9507 Luminometer (Perkin Elmer Wallac, Gaithersburg, MD, USA). Transfections and assays were performed in triplicate three to seven times, with different DNA preparations of the same clones to insure validity. The normalized luciferase data (Renilla/firefly) were used to perform the statistics, and the data for rhesus monkey 3 0 -UTR haplotypes were then expressed relative to the haplotype ACS.
Data analysis and bioinformatics
Software BioEdit version 5.0 (http://www.mbio.ncsu. edu/BioEdit/bioedit.html) was used to analyze the DNA sequencing data. Statistics were performed using StatView 5.0 software (SAS Institute Inc., USA). Comparison of the plasma cortisol levels, dexamethasone-suppressed degree of urinary-free cortisol, and the luciferase activity between genotype and haplotype groups were performed by using analysis of variance (ANOVA), followed by Fisher's protected least significant difference (PLSD) test. Linkage disequilibrium (LD) analysis and haplotype construction was carried out by using the Innate Immunity PGA, NHLBI Program LDPlotter and Phase (https:// innateimmunity.net/IIPGA2/Bioinformatics/), with the D 0 value being used to evaluate the LD between polymorphisms. The secondary structure of mRNA was predicted using Mfold program (http:// www.bioinfo.rpi.edu/applications/mfold). 24 
Results

TPH2 coding region sequence
The full length of rhesus monkey TPH2 coding region, integrated with a comparison of both nucleotide and amino-acid sequence between rhesus monkey and human, are shown in Figure 1 . There is a similarity of > 98% between the two species for both nucleotide and amino-acid sequence, with only six nonidentical amino acids being observed. The sequence of rhesus monkey TPH2 coding region was deposited in Genbank (DQ360113).
TPH2 polymorphisms and LD analysis
As shown in Figure 2 and Table 3 , we identified a total of 21 polymorphisms in rhesus monkey TPH2, including 17 SNPs, two mononucleotide repeats, one dinucleotide repeat and one 159-bp insertion polymorphism, with most of them having a minor allele frequency > 0.05. These polymorphisms spread widely over TPH2, with four in the 5 0 -FR, three in the 3 0 -UTR, six in the coding region and eight in the introns. Of the six coding SNPs, the 74C > A and 223G > A in exon 1 and 2, respectively, were predictive of an amino-acid change (25Pro > His and 75Gly > Ser, respectively). A 159-bp insert in 3 0 -UTR was verified to be a duplication of partial intron 9 sequence. Detailed position and frequency of each polymorphism are given in Table 3 , while the trace chromatogram and gel-based detection assay for some polymorphisms are shown in Figures 3 and 4 . For the cohort of 32 monkeys, detailed genotype distribution and allele frequencies of the related polymorphisms are shown in Table 4 . An example of the melting curve analysis for 223G > A genotyping is shown in Figure 5 . Figure 2 shows that about four LD blocks were formed due to the significant LD between some neighboring polymorphisms. Particularly, the three common polymorphisms in 3 0 -UTR constituted a block of consistently high LD, within which the 1503A > G and 2128S > L are completely linked with each other, with the A or G allele at 1503 being predictive of the S or L allele at 2128, or conversely, while the C allele at 2051 is always accompanied by 1503A/2128S allele but never by 1503G/2128L. Thus, these three 3 0 -UTR polymorphisms constitute only three haplotypes: AAS, ACS, and GAL. The frequencies of the AAS, ACS, and GAL haplotypes in 84 monkeys (52 sequenced and 32 in cohort) were 24.4, 49.4 and 26.2%, respectively.
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Genotype-phenotype relationship
Genotype-phenotype relationships were examined for the 3 0 -UTR polymorphisms and haplotypes, as well as the -363T > G. As the 1503A > G and 2128S > L are completely linked, only 2128S > L was used for association and its potential interaction with 2051A > C was taken into account. For the À363T > G, as shown in Figure 6 , except for a significant association with dexamethasone suppression test, no relationship was found between the genotype and other two variables (plasma cortisol level and DEX/ACTH challenge response). However, as mentioned hereinafter, significant relationship was found between all variables for HPA axis function and the 3 0 -UTR polymorphisms and haplotypes, especially the 2051A > C polymorphism.
As shown in Figure 7 and Table 5 , the 2051CC homozygotes had higher AM cortisol level than AA homozygotes and AC heterozygotes (overall F = 10.203, P = 0.001, with P = 0.0004 and 0.0028 for CC vs AA and CC vs AC, respectively), with no overlapping being observed between AA and CC -1605T>C -1491Tn -1485(AT)n -363T>G 74C>A* 223G>A* IVS5-3C>T  IVS6-101C>T   867A>G  915C>T  945T>C  IVS8-40C>A  IVS8-3Tn  IVS9+104A>T  IVS9-217C>T  IVS9-56C>T  IVS9-24C>T  I206A>G  1503A>G  2051A>C groups. This pattern of difference was still observed after stratification by 2128S > L. For instance, in monkeys with the same 2128SS genotype, the 2051CC homozygotes showed a significantly higher AM cortisol level than 2051AA/AC genotypes (overall F = 5.747, P = 0.0246). Thus, the association of 2051A > C with AM cortisol level was independent of 2128S > L. Neither 2051A > C nor 2128S > L was significantly associated with PM cortisol level. The only one 2128LL homozygote in the cohort showed no dexamethasone suppression, whereas the four monkeys with 100% suppression were all 2128SS homozygotes. For monkeys with 2051AA/ AC genotypes, both DEX-N and DEX-D differed significantly between the three 2128S > L genotypes, with SS > SL > LL (P = 0.0031 and 0.0016 for DEX-N and DEX-D, respectively). For monkeys with the same 2128SS genotype, significantly lower DEX-D but not DEX-N was observed between 2051CC and AA/AC genotypes (P = 0.0048). In addition, the 2051CC homozygotes showed a higher DEX/ACTH challenge response than AA homozygotes, and this difference was statistically significant at 30 min (P = 0.0189) and marginally significant at 15 min (P = 0.0517). A similar tendency was also observed after stratification by 2128S > L.
As shown in Figure 8 , HPA axis activity also differed between monkeys grouped by 3 0 -UTR haplotype pairs. Compared to the other five haplotype pairs, the ACS/ACS homozygotes showed a significantly higher AM cortisol level (F = 4.303, P = 0.0113) and a tendency of having higher DEX/ACTH challenge response. For the dexamethasone suppression, significant difference were also found between some haplotype pairs.
Luciferase reporter gene assay Significant difference in luciferase activity were found between 3 0 -UTR haplotypes of rhesus monkey TPH2, but not between 1952G and 1952A constructs of human TPH2 3 0 -UTR. As shown in Figure 9 , in both HEK-293 and SK-N-MC cell lines, and in vectors driven by either SV40 or TK promoter, the ACS haplotype always showed the lowest luciferase activity, whereas the GAL haplotype had the highest luciferase activity. On most occasions, the AAS haplotye had an intermediate luciferase activity while the AAL haplotype showed a similar luciferase activity with GAL haplotype. Before the AAS haplotype construct was generated, we had also compared the expressed luciferase activity between ACS and GAL constructs on at least six occasions (harvested between 24 and 96 h after transfection) by using single Renilla luciferase assays, and each time the GAL construct expressed strikingly higher luciferase activity than the ACS construct (data not shown), as later replicated with the dual luciferase reporter assay.
The significance of each polymorphism alone was evaluated by comparing two constructs that differed at only the given locus. As no remarkable difference in luciferase activity was found between GAL and AAL haplotypes, it is unlikely that 1503A > G would significantly affect gene expression. In contrast, comparison between the ACS, AAS and AAL showed that both 2051C and 2128S > L have a profound effect on gene expression, with the 2051C and 2128L alleles being indicative of a relatively lower and higher gene expression, respectively.
Mfold prediction of mRNA secondary structure The full length of rhesus monkey TPH2 mRNA, which is modified from human TPH2 mRNA (AY098914), was submitted to secondary structure prediction by Mfold. As shown in Figure 10 , both 2051A > C and 2128S > L, but not 1503A > G, might lead to a change in mRNA secondary structure. In particular, a stem formed by dozens of nucleotides surrounding 2051A > C presents in both AAS and GAL haplotypes, but not in ACS haplotype.
Discussion
This study is our initial step towards the development of the non-human primate as a natural model of human TPH2 genetic variance. We have identified numerous polymorphisms in rhesus monkey TPH2, and assessed the functional significance of common 3 0 -UTR polymorphisms in both rhesus monkey and human TPH2. We also revealed a homology of more than 98% between the human and rhesus monkey TPH2 coding regions, supporting the advantage of this non-human primate in modeling genotypephenotype associations relevant to humans. Like human TPH2, there are common polymorphisms in both 5 0 -FR and 3 0 -UTR of the rhesus monkey TPH2. Functional polymorphism(s) regulating TPH2 gene expression might thus exist in both species, making it possible that different polymorphisms in humans and rhesus monkeys may result in similar effects, providing us the opportunity to develop rhesus monkey as natural models of human TPH2 genetic variance for unraveling genotype-phenotype relationships relevant to human disorders. However, although several common polymorphisms in both 5 0 -FR and 3 0 -UTR of human TPH2 have been identified, and the common À844G > T in 5 0 -FR has been reported to be associated with amygdala reactivity, 20 ,21 their effect on TPH2 gene expression is still undetermined. In the present study, while the functional significance of common 3 0 -UTR polymorphisms in rhesus monkey TPH2 were identified, we also assessed the functional significance of a common 3 0 -UTR SNP (1952G > A, rs17110747) in human TPH2 but found no effect on in vitro gene expression for this polymorphism. The functional study for the 5 0 -FR polymorphisms in both rhesus monkey and human TPH2 is currently undertaken in our laboratory. With respect to the polymorphisms in rhesus monkey TPH2 coding region, we found no missense coding SNP within or close to exon 11, where the previously reported human TPH2 1463G > A (441R > H) resides; 8 however, this 1463G > A functional polymorphism is Figure 5 not yet verified by others even in a total population of nearly 5000 subjects sampled from multiple ethnic groups. Instead, several additional uncommon missense variants were observed in human TPH2, 17 among which the 41Ser > Tyr and 5Arg > Cys had a parallel location to the 25Pro > His and 75Gly > Ser that we identified in rhesus monkey TPH2. The functional significance of 25Pro > His and 75Gly > Ser is also under investigation in our laboratory, in comparison to human 41Ser > Tyr and 5Arg > Cys.
It has been well documented that the 3 0 -UTR contains regulatory elements that have important roles in post-transcriptional control of gene expression, and accordingly an increasing number of polymorphisms in 3 0 -UTR have been demonstrated to be functionally significant. 25, 26 In our present study, all the in vivo genotype-phenotype relationship, in vitro gene expression assay and mRNA secondary structure prediction pointed to the functional significance of the 2051A > C and 2128S > L polymorphisms in 3 0 -UTR of rhesus monkey TPH2. As for the mechanism(s), it is likely that the alteration in mRNA secondary structure caused by 2051A > C and 2128S > L might influence its stability, localization and translatability, and thereby result in the change in gene expression. Both 2051A > C and 2128S > L had a profound effect on in vitro gene expression, but the in vivo genotype-phenotype association showed apparently more significance of 2051A > C than 2128S > L. This discrepancy between the in vivo and in vitro data is possibly due to the difference in allele frequency between the two polymorphisms (0.469 for 2051C and 0.250 for 2128L, respectively), because the less available sample size in 2128S > L genotype groups will greatly decrease statistical power. For example, in monkeys with the same 2051AA genotype, there was only one homozygote for 2128SS and 2128LL, respectively. Thus, with the interaction of the linked 2051A > C, the association of the 2128S > L polymorphism with HPA axis activity might be obscured due to the limited sample size. However, other unknown functional polymorphisms in 5 0 -FR or other regions may have less or more of an effect on the association of these two 3 0 -UTR polymorphisms, despite no significant LD being found between them. In the present study, however, we did not focus on the 5 0 -FR polymorphisms because they are much more complicated than the 3 0 -UTR polymorphisms, also no significant association was observed between the HPA axis activity and the common À363T > G polymorphism in 5 0 -FR. The HPA axis is a critical neuroendocrine system that responds to stress and dysfunction of this system is involved in a wide variety of diseases, including numerous neuropsychiatric disorders. It is well known that 5-HT plays an important role in the regulation of HPA axis, generally as an activator of this system at different levels, and in turn the HPA axis also regulates the central serotonergic activity. 27, 28 Thus, our finding of the association between functional TPH2 polymorphisms and HPA axis activity highly suggests that TPH2 might regulate HPA function by modulating 5-HT synthesis and serotonergic tone. Interestingly, the 2051A > C polymorphism was strikingly associated with AM cortisol level but not PM cortisol level, coinciding with the circadian rhythm of the HPA axis and cortisol surge in the morning. This polymorphism was also associated with DEX/ACTH challenge response, implying that TPH2 might be involved in the activation of HPA axis in the morning or in response to stress. In support of this presumption, a circadian rhythm of TPH2 expression has been reported. 5 Moreover, in agreement with the reported downregulation of TPH2 mRNA expression by dexmethasone, 29 the 2128L allele with higher in vitro gene expression showed lower dexamethasone suppression, suggesting that TPH2 might also be involved in the negative feedback of HPA axis. In the present study, we observed that the 2051C allele (or ACS haplotype) with lower in vitro gene expression was associated with higher AM cortisol level and DEX/ACTH challenge response, while the 2051A allele with higher in vitro gene expression was correlated to lower AM cortisol level and DEX/ACTH challenge response. In other words, a lower basal TPH2 expression or 5-HT level might render a higher HPA axis responsiveness, and inversely a higher basal TPH2 expression or 5-HT level might suggest a lower HPA axis responsiveness. This observation is supported by the notion that 5-HT deficiency and HPA hyperactivity are involved in major depression and many other psychiatric disorders. 30, 31 Although the underlying mechanisms are yet to be determined, the upregulation or downregulation of related receptors might be contributive. On the other hand, this observation seems to be in contradiction with the previous finding of elevated TPH2 expression in depressed suicidal victims; however, it has been recognized that 5-HT deficiency in some subsets of depression was due to disturbance in 5-HT receptor or transporter but not lack of 5-HT, and in this situation the increased TPH2 expression was a compensatory response to 5-HT deficiency. 32 Owing to the diversity of complex diseases, altered TPH2 expression might also act as a causative factor in the etiology of depression or other related diseases, at least for some subsets of those diseases. Nevertheless, because of the possible discrepancies between the in vivo and in vitro gene expression, our finding and its underlying mechanisms warrant verification by further studies and further assessments with more comprehensive haplotypes.
Our finding of the association between functional TPH2 polymorphisms and HPA axis function might shed light on role of TPH2 in the pathophysiology of numerous psychiatric disorders. As HPA dysfunction Means marked with the same letter were not significantly differed (between 2051A > C genotypes). Data was shown as mean7s.d., with sample size listed in parentheses. is involved in a wide variety of psychiatric diseases, it is not strange that an accumulating body of disorders are found to be associated with TPH2 genetic variance. In addition, as the HPA axis is anatomically connected and influenced by amygdaloid function, our finding is also in agreement with the replicated observation that the amygdala reactivity or responsiveness is modulated by the promoter À844G > T polymorphism in human TPH2. 20, 21 More recently, in a preliminary investigation of serotonin-related genes in alcoholism, we found one rhesus monkey homozygous for ACS haplotype that showed much less time to achieve stable self-administration and striking higher maximal alcohol intake than monkeys with other haplotypes (data not shown). This observation is in good accordance with the previous reports that dysfunction of the HPA axis is involved in alcoholism and a subset of alcoholics showed high basal cortisol levels. [33] [34] [35] In summary, our present study has revealed that rhesus monkey TPH2 has a high similarity with human TPH2 and is highly polymorphic, and more important, we have identified the functional significance of polymorphisms in 3 0 -UTR of rhesus monkey TPH2. The association of functional TPH2 polymorphism with HPA axis activity highly suggests that TPH2 might constitute an important modulator for the regulation of HPA function by controlling the synthesis of 5-HT and serotonergic tone. Our findings elaborate our understanding of the regulation of TPH2 gene expression, and also provide new insights into the role of TPH2 in the pathophysiology of neuropsychiatric diseases. 
